Anna Schwartz to Treatment Outcome
This is a "connection" page, showing publications Anna Schwartz has written about Treatment Outcome.
Connection Strength
0.681
-
Trendowski MR, Lusk CM, Ruterbusch JJ, Seaton R, Simon MS, Greenwald MK, Harper FWK, Beebe-Dimmer JL, Schwartz AG. Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Med. 2021 11; 10(22):8151-8161.
Score: 0.154
-
Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, Simon MS, Abrams J, Schwartz KL, Schwartz AG. The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):666-674.
Score: 0.126
-
Schwartz AL, Biddle-Newberry M, de Heer HD. Randomized trial of exercise and an online recovery tool to improve rehabilitation outcomes of cancer survivors. Phys Sportsmed. 2015 May; 43(2):143-9.
Score: 0.097
-
Schwartz AL, Winters-Stone K. Effects of a 12-month randomized controlled trial of aerobic or resistance exercise during and following cancer treatment in women. Phys Sportsmed. 2009 Oct; 37(3):62-7.
Score: 0.067
-
Schwartz AL. Physical activity. Semin Oncol Nurs. 2008 Aug; 24(3):164-70.
Score: 0.062
-
Schwartz AL. Exercise regimen reduces fatigue. Oncology (Williston Park). 2007 Apr; 21(4 Suppl):37-9.
Score: 0.056
-
Schwartz AL. Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest. 2004; 22(1):82-92.
Score: 0.045
-
Wilkie DJ, Schwartz AL, Liao WC, Fullwood D, Wu Y, Farquharson TW, Yao Y, Gralow JR. Reduced Cancer-Related Fatigue after Tablet-Based Exercise Education for Patients. Cancer Control. 2022 Jan-Dec; 29:10732748221087054.
Score: 0.039
-
Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer. 2012 Apr 15; 118(8 Suppl):2270-6.
Score: 0.020
-
Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer. 2008 Oct; 16(10):1179-88.
Score: 0.015